Search Immortality Topics:

Page 10,579«..1020..10,57810,57910,58010,581..10,59010,600..»


Izzie Stevens What Doesn’t Kill you Makes you Stronger 0001 – Video

Posted: December 9, 2012 at 6:40 pm


Izzie Stevens What Doesn #39;t Kill you Makes you Stronger 0001
A tribute to my favourite character from grey #39;s anatomy, the extraordinary and beautiful, Izzie Stevens played by Katherine Heigl. Izzie, in my opinion has been through a lot but has always came out stronger, hence the song. Song-What Doesn #39;t Kill You Makes You Stronger: Kelly ClarksonFrom:Honeybear8262Views:0 0ratingsTime:01:03More inEntertainment

Originally posted here:
Izzie Stevens What Doesn't Kill you Makes you Stronger 0001 - Video

Recommendation and review posted by G. Smith

Geeorj’s ‘Anatomy of a Full Band Cover’ – Video

Posted: December 9, 2012 at 6:40 pm


Geeorj #39;s #39;Anatomy of a Full Band Cover #39;
500 Subscribers! Cheers everyone ๐Ÿ™‚ If anyone #39;s watching who knows this stuff more than I, suck on these socks. http://www.facebook.com http://www.twitter.com http://www.soundcloud.comFrom:GeeorjMusicViews:1 0ratingsTime:20:50More inMusic

The rest is here:
Geeorj's 'Anatomy of a Full Band Cover' - Video

Recommendation and review posted by G. Smith

$40 Million High-Risk Stem Cell Research; IOM and CIRM on Engaging Biotech Biz

Posted: December 9, 2012 at 5:13 pm

Directors of the California stem cell
agency this Wednesday will be asked to approve initiation of a $40 million, high-risk research program aimed at filling “key gaps”
in knowledge about human stem cell behavior.

The concept plan for the round –
called Basic Biology V – will come up for approval at the governing board meeting in Los Angeles.  Pre-applications are expected to be due
in March.
The staff proposal calls
for as many as 30 awards, but did not specify a limit on the total dollars for each award. The competition is open to both business and academics
and non-profit organizations.
The proposal said that the round is
targeting “high-risk, exploratory pursuits.” The goal is to fill
“key gaps in our understanding of fundamental human stem cell
behaviors that hinder the pace of discovery, and ultimately prevent
the potential of this research from being fully realized.”
Additionally up for consideration at this
week's meeting is a “blueprint” for “engaging industry and supporting commercialization” of CIRM research. A blue-ribbon study
by the Institute of Medicine last week also recommended that CIRM
engage industry more warmly. However, there were striking differences
between what the IOM recommended and what CIRM proposed. The CIRM plan was prepared
prior to the release of the IOM report. 
The CIRM proposal laid out the following
objectives that were prompted by an “external review” two years
ago.
  •  “Attract Follow-On Financing and
    Co-funding of CIRM Funded Research
  •  “Support of Company
    Creation/Growth/Relocation
  • “Early Engagement of Top Tier
    Biopharmaceutical Companies in Order to Access Critical Expertise
  • “Assume a Leadership Role in
    Business Related Areas the are Critical for Supporting the Field”

The CIRM memo listed a number of
initiatives that the agency has already started and said more are
expected to come. They include the already enacted, new business-friendly
award program, the recent hire of an unidentified business
development officer, designation of industry “collaborators,”
relocation support for high impact companies and participation with
industry in developing “reimbursement pathways” that will benefit
the regenerative medicine industry.

“Reimbursement” is the euphemistic
term that industry prefers instead of saying “beefing up profits.”
Last week, the report by the Institute of Medicine, which cost CIRM $700,000,  noted that biotech firms have
received only about 6 percent of the $1.7 billion handed out by CIRM,
a figure not mentioned by the eight-year-old agency's industry
engagement plan.
The IOM said that industry
representation on the agency's critical, decision-making boards (the governing board and standards and
grant reveiew groups) should be enhanced. Additionally, a new scientific advisory
board with substantial industry presence should be created to replace
existing advisory groups. All of which would be aimed at enhancing
and leveraging industry “expertise and resources in product
development, manufacturing, and regulatory approval in support of
the ultimate goal of bringing therapies to patients,” according to
the IOM.  

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/Mq5Z-PgI3cY/40-million-high-risk-stem-cell-research.html

Recommendation and review posted by G. Smith

At Some Point Soon, Mouth Bacteria Will Be Defeated

Posted: December 9, 2012 at 7:51 am

The modern age of antibiotics didn't do a great deal to combat the inexorable processes that contribute to tooth decay and gum disease, as it things turned out. One might have thought so at the outset: bacteria in the mouth are causing issues, we're developing all sorts of enormously improved methods of killing bacteria, ergo tooth decay and commonplace gum disease like gingivitis and should soon be a thing of the past. Alas not so, however - nothing is straightforward in the world of medicine. As one consideration, many of the hundreds of bacterial species in the mouth are actually beneficial.

In recent years, there has been some progress towards more sophisticated solutions. These include methods of sabotaging key mechanisms in problem bacterial species so as to leave other bacteria unharmed, or of targeting bacteria by their surface chemistry or other markers. For example:

I noticed another line of work in this field; here researchers are sabotaging the progression of gum inflammation caused by bacteria:

Penn-Led Research Suggests a New Strategy to Prevent or Halt Periodontal Disease

Porphyromonas gingivalis, the bacterium responsible for many cases of periodontitis, acts to "hijack" a receptor on white blood cells called C5aR. The receptor is part of the complement system, a component of the immune system that helps clear infection but can trigger damaging inflammation if improperly controlled. By hijacking C5aR, P. gingivalis subverts the complement system and handicaps immune cells, rendering them less able to clear infection from the gum tissue. As a result, numbers of P. gingivalis and other microbes rise and create severe inflammation. According to a study published [last year], mice bred to lack C5aR did not develop periodontitis.

[The] researchers synthesized and administered a molecule that blocks the activity of C5aR, to see if it could prevent periodontitis from developing. They gave this receptor "antagonist," known as C5aRA, to mice that were then infected with P. gingivalis. The C5aRA injections were able to stave off inflammation to a large extent, reducing inflammatory molecules by 80 percent compared to a control, and completely stopping bone loss. And when the mice were given the antagonist two weeks after being infected with P. gingivalis, the treatment was still effective, reducing signs of inflammation by 70 percent and inhibiting nearly 70 percent of periodontal bone loss.

I suspect that the next generation will very rarely visit dentists, as much of the need for regular dental services will be removed by products based on this and similar sorts of research.

Source:
http://www.fightaging.org/archives/2012/12/at-some-point-soon-mouth-bacteria-will-be-defeated.php

Recommendation and review posted by Fredricko

PGC-1 alpha-4 Spurs Muscle Growth

Posted: December 9, 2012 at 7:51 am

Researchers have found a number of potential ways to spur growth of muscle tissue, and some of these might be used in attempts to fend off the loss of muscle mass and strength that occurs with aging - not by fixing the root causes, but by trying to compensate through another mechanism. Here is a recent example:

The protein is an isoform, or slight variant, of PGC-1 alpha, an important regulatory of body metabolism that is turned on by forms of exercise, such as running, that increase muscular endurance rather than size. [A rise in] PGC-1 alpha-4 with exercise increases activity of a protein called IGF1 (insulin-like growth factor 1), which facilitates muscle growth. At the same time, PGC-1 alpha-4 also represses another protein, myostatin, which normally restricts muscle growth. In effect, PGC-1 alpha-4 presses the accelerator and removes the brake to enable exercised muscles to gain mass and strength.

Several experiments demonstrated the muscle-enhancing effects of the novel protein. The investigators used virus carriers to insert PGC-1 alpha-4 into the leg muscle of mice and found that within several days their muscle fibers were 60 percent bigger compared to untreated mice. They also engineered mice to have more PGC-1 alpha-4 in their muscles than normal mice who were not exercising. Tests showed that the treated mice were 20 percent stronger and more resistant to fatigue than the controls; in addition, they were leaner than their normal counterparts.

Link: http://www.sciencedaily.com/releases/2012/12/121206121728.htm

Source:
http://www.fightaging.org/archives/2012/12/pgc-1-alpha-4-spurs-muscle-growth.php

Recommendation and review posted by Fredricko

Being Older is Very Positive, Being Aged is Not

Posted: December 9, 2012 at 7:51 am

It should be noted that, on balance, everything except physical health becomes better with age. Outside of degenerative aging, becoming older is so good that people are driven to apologism for the fact that aging cripples and kills them - they conflate being old and being aged, seeing two very different things as one, and a certain confusion arises after that point.

Consider how much better it will be to be older once we start being able to treat the root causes of the degenerative medical condition called aging. If you're not there yet, consider just how good being older must be in order for people to be able to say they are well off even while their health is crumbling:

The SAGE study included adults between the ages of 50 and 99 years, with a mean age of just over 77 years. In addition to measures which assessed rates of chronic disease and disability, the survey looked at more subjective criteria such as social engagement and participants' self-assessment of their overall health.

Participants were asked to rate the extent to which they thought they had "successfully aged," using a 10-point scale and using their own concept of the term. The study found that people with low physical functioning but high resilience, had self-ratings of successful aging similar to those of physical healthy people with low resilience. Likewise, the self-ratings of individuals with low physical functioning but no or minimal depression had scores comparable to those of physically healthy people with moderate to severe depression.

"It was clear to us that, even in the midst of physical or cognitive decline, individuals in our study reported feeling that their well-being had improved with age."

Link: http://www.eurekalert.org/pub_releases/2012-12/uoc--poa120312.php

Source:
http://www.fightaging.org/archives/2012/12/being-older-is-very-positive-being-aged-is-not.php

Recommendation and review posted by Fredricko


Page 10,579«..1020..10,57810,57910,58010,581..10,59010,600..»